Biechele Royce Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Biechele Royce Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-105,677	Closed	-$6.76M	–	66
2023 Q2	$6.76M	Sell	105,677 -8,686	-8%	-$582K	2.35%	18
2023 Q1	$7.93M	Sell	114,363 -5,109	-4%	-$360K	2.95%	16
2022 Q4	$8.6M	Sell	119,472 -5,712	-5%	-$431K	3.51%	15
2022 Q3	$8.9M	Sell	125,184 -10,619	-8%	-$770K	4.19%	8
2022 Q2	$10.5M	Sell	135,803 -5,804	-4%	-$442K	4.65%	5
2022 Q1	$10.3M	Sell	141,607 -1,747	-1%	-$117K	4.12%	10
2021 Q4	$8.94M	Buy	143,354 +5,715	+4%	+$335K	3.58%	12
2021 Q3	$8.14M	Buy	137,639 +3,674	+3%	+$242K	3.6%	12
2021 Q2	$8.95M	Buy	133,965 +5,155	+4%	+$336K	3.88%	11
2021 Q1	$8.13M	Buy	128,810 +74,600	+138%	+$4.64M	4.09%	11
2020 Q4	$3.36M	Sell	54,210 -271	-0.5%	-$16.7K	1.9%	20
2020 Q3	$3.29M	Sell	54,481 -1,586	-3%	-$95.5K	2.07%	22
2020 Q2	$3.3M	Sell	56,067 -594	-1%	-$35.5K	2.08%	20
2020 Q1	$3.16M	Sell	56,661 -3,141	-5%	-$192K	2.43%	19
2019 Q4	$3.84M	Sell	59,802 -1,165	-2%	-$66.7K	2.31%	20
2019 Q3	$3.09M	Buy	60,967 +2,952	+5%	+$139K	2.04%	22
2019 Q2	$2.63M	Buy	58,015 +3,114	+6%	+$145K	1.74%	22
2019 Q1	$2.62M	Buy	54,901 +2,477	+5%	+$123K	1.7%	24
2018 Q4	$2.73M	Sell	52,424 -593	-1%	-$31.9K	1.96%	22
2018 Q3	$3.29M	Sell	53,017 -45,446	-46%	-$2.7M	2.06%	21
2018 Q2	$5.45M	Buy	98,463 +7,704	+8%	+$416K	3.65%	8
2018 Q1	$5.74M	Buy	90,759 +935	+1%	+$60.1K	4.01%	8
2017 Q4	$5.5M	Buy	+89,824	New	+$5.62M	3.74%	9

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Biechele Royce Advisors's BMY Position: Q3 2023 in Review

Biechele Royce Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 105,677 shares — an estimated $6.76M sold.

Biechele Royce Advisors first reported a position in BMY in Q4 2017 and held it in 23 quarters. The position peaked at $10.5M in Q2 2022. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Biechele Royce Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
Biechele Royce Advisors sold 105,677 Bristol-Myers Squibb shares in Q3 2023, an estimated $6.76M.
Biechele Royce Advisors first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 23 quarters.
Biechele Royce Advisors's Bristol-Myers Squibb position peaked at $10.5M in Q2 2022.
2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Biechele Royce Advisors's 13F filing for Q3 2023, filed 1 Nov 2023.